BioRestorative Therapies, Inc. (BRTX)Healthcare | Biotechnology | Melville, United States | NasdaqCM
0.26 USD
+0.01
(2.607%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.26 -0.01 (-0.005%) ⇩ (April 17, 2026, 7:22 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 7:24 p.m. EDT
BRTX presents a high-risk, low-confidence speculative opportunity where technical and statistical evidence overwhelmingly outweighs optimistic analyst targets. Despite a 'strong buy' consensus from analysts with targets as high as $15, the stock is fundamentally crippled: it has no dividend history, negative earnings, negative free cash flow, and shrinking revenue (-54.7%). The statistical model for the next 45 days predicts a 23.5% decline, confirmed by highly significant Ljung-Box and Jarque-Bera p-values that indicate non-random, chaotic price behavior. Furthermore, recent headlines confirm massive share dilution via public offerings, which drags on share price, while the current price remains well below its 50-day and 200-day moving averages. The combination of a 'strong buy' recommendation for a company burning cash, diluting shareholders, and a statistical model predicting further downside makes this a 'slight downside lean' for the short term and a 'slightly bearish' long-term hold due to structural value erosion. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 1.148308 |
| AutoARIMA | 1.214849 |
| AutoETS | 1.216401 |
| MSTL | 1.224436 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 1.87 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 0.73 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 11.852 |
| Revenue per Share | 0.04 |
| Market Cap | 6,718,594 |
| Forward P/E | -0.51 |
| Beta | 0.27 |
| Website | https://www.biorestorative.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8457895 |
| Address1 | 40 Marcus Drive |
| Address2 | Suite 1 |
| All Time High | 156,000.0 |
| All Time Low | 0.19 |
| Ask | 0.327 |
| Ask Size | 2 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 1,671,670 |
| Average Daily Volume3 Month | 9,538,761 |
| Average Volume | 9,538,761 |
| Average Volume10Days | 1,671,670 |
| Beta | 0.266 |
| Bid | 0.1796 |
| Bid Size | 2 |
| Book Value | 0.039 |
| City | Melville |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.2637 |
| Current Ratio | 0.843 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.2637 |
| Day Low | 0.2503 |
| Debt To Equity | 11.852 |
| Display Name | BioRestorative Therapies |
| Earnings Call Timestamp End | 1,747,254,600 |
| Earnings Call Timestamp Start | 1,747,254,600 |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda | -15,437,147 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.248 |
| Enterprise To Revenue | 10.625 |
| Enterprise Value | 3,821,935 |
| Eps Current Year | -0.66 |
| Eps Forward | -0.52 |
| Eps Trailing Twelve Months | -1.58 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.315622 |
| Fifty Day Average Change | -0.051921993 |
| Fifty Day Average Change Percent | -0.16450688 |
| Fifty Two Week Change Percent | -84.57895 |
| Fifty Two Week High | 2.045 |
| Fifty Two Week High Change | -1.7813001 |
| Fifty Two Week High Change Percent | -0.8710514 |
| Fifty Two Week Low | 0.19 |
| Fifty Two Week Low Change | 0.07370001 |
| Fifty Two Week Low Change Percent | 0.3878948 |
| Fifty Two Week Range | 0.19 - 2.045 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,354,717,800,000 |
| Float Shares | 24,175,216 |
| Forward Eps | -0.52 |
| Forward P E | -0.5071154 |
| Free Cashflow | -6,200,023 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 13 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.93371004 |
| Gross Profits | 335,856 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12128 |
| Held Percent Institutions | 0.04561 |
| Implied Shares Outstanding | 25,478,172 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-11-05 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,635,292,800 |
| Last Split Factor | 1:4000 |
| Long Business Summary | BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York. |
| Long Name | BioRestorative Therapies, Inc. |
| Market | us_market |
| Market Cap | 6,718,594 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_58274944 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -14,241,975 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 6,693,115 |
| Number Of Analyst Opinions | 2 |
| Open | 0.2516 |
| Operating Cashflow | -10,788,963 |
| Operating Margins | -195.16838 |
| Payout Ratio | 0.0 |
| Phone | 631 760 8100 |
| Post Market Change | -0.005400002 |
| Post Market Change Percent | -2.0477822 |
| Post Market Price | 0.2583 |
| Post Market Time | 1,776,468,132 |
| Previous Close | 0.257 |
| Price Eps Current Year | -0.39954546 |
| Price Hint | 4 |
| Price To Book | 6.7615385 |
| Price To Sales Trailing12 Months | 18.678326 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.797 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.00670001 |
| Regular Market Change Percent | 2.60701 |
| Regular Market Day High | 0.2637 |
| Regular Market Day Low | 0.2503 |
| Regular Market Day Range | 0.2503 - 0.2637 |
| Regular Market Open | 0.2516 |
| Regular Market Previous Close | 0.257 |
| Regular Market Price | 0.2637 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 1,498,997 |
| Return On Assets | -1.19557 |
| Return On Equity | -3.2047198 |
| Revenue Growth | -0.547 |
| Revenue Per Share | 0.04 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 25,478,170 |
| Shares Percent Shares Out | 0.035 |
| Shares Short | 890,908 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 787,086 |
| Short Name | BioRestorative Therapies, Inc. |
| Short Percent Of Float | 0.0355 |
| Short Ratio | 0.09 |
| Source Interval | 15 |
| State | NY |
| Symbol | BRTX |
| Target High Price | 15.0 |
| Target Low Price | 1.0 |
| Target Mean Price | 8.0 |
| Target Median Price | 8.0 |
| Total Cash | 2,952,922 |
| Total Cash Per Share | 0.116 |
| Total Debt | 42,282 |
| Total Revenue | 359,700 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.58 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.123939 |
| Two Hundred Day Average Change | -0.860239 |
| Two Hundred Day Average Change Percent | -0.7653787 |
| Type Disp | Equity |
| Volume | 1,498,997 |
| Website | https://www.biorestorative.com |
| Zip | 11,747 |